Neurologic Stem Cell Treatment Study
NCT02795052
This study is recruiting at 2 US sites in 2 states, according to its ClinicalTrials.gov record last updated .
Summary
This is a human clinical study involving the isolation of autologous bone marrow derived stem cells (BMSC) and transfer to the vascular system and inferior 1/3 of the nasal passages in order to determine if such a treatment will provide improvement in neurologic function for patients with certain neurologic conditions. http://mdstemcells.com/nest/
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Neurologic Disorders
- Nervous System Diseases
- Neurodegenerative Diseases
- Neurological Disorders
- Stroke
- Traumatic Brain Injury
- Cadasil
- Chronic Traumatic Encephalopathy
- Cerebral Infarction
- Cerebral Ischemia
- Cerebral Stroke
- Cerebral Hemorrhage
- Parkinson
- Multi-System Degeneration
- MSA - Multiple System Atrophy
- Progressive Supranuclear Palsy
- ALS
- Amyotrophic Lateral Sclerosis
- Neuropathy
- Diabetic Neuropathies
- Alzheimer Disease
- Dementia
- Frontotemporal Dementia
- Lewy Body Disease
- Cognitive Impairment
- Lewy Body Variant of Alzheimer Disease
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- MD Stem Cells
- Last updated on ClinicalTrials.gov
- June 26, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Connecticut · 1
- MD Stem Cells · Westport, CT
Florida · 1
- MD Stem Cells · Coral Springs, FL
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.